|
1
|
Chalasani N, Younossi Z, Lavine JE, et al:
The diagnosis and management of non-alcoholic fatty liver disease:
practice Guideline by the American Association for the Study of
Liver Diseases, American College of Gastroenterology, and the
American Gastroenterological Association. Hepatology. 55:2005–2023.
2012. View Article : Google Scholar
|
|
2
|
Adams LA, Lymp JF, St Sauver J, et al: The
natural history of nonalcoholic fatty liver disease: a
population-based cohort study. Gastroenterology. 129:113–121. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dunn W, Xu R, Wingard DL, et al: Suspected
nonalcoholic fatty liver disease and mortality risk in a
population-based cohort study. Am J Gastroenterol. 103:2263–2271.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ascha MS, Hanouneh IA, Lopez R, Tamimi TA,
Feldstein AF and Zein NN: The incidence and risk factors of
hepatocellular carcinoma in patients with nonalcoholic
steatohepatitis. Hepatology. 51:1972–1978. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chatrath H, Vuppalanchi R and Chalasani N:
Dyslipidemia in patients with nonalcoholic fatty liver disease.
Semin Liver Dis. 32:22–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Musso G, Gambino R, Cassader M and Pagano
G: Meta-analysis: natural history of non-alcoholic fatty liver
disease (NAFLD) and diagnostic accuracy of non-invasive tests for
liver disease severity. Ann Med. 43:617–649. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Festi D, Schiumerini R, Marzi L, et al:
Review article: the diagnosis of non-alcoholic fatty liver disease
- availability and accuracy of non-invasive methods. Aliment
Pharmacol Ther. 37:392–400. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miyake T, Kumagi T, Hirooka M, et al: Body
mass index is the most useful predictive factor for the onset of
nonalcoholic fatty liver disease: a community-based retrospective
longitudinal cohort study. J Gastroenterol. 48:413–422. 2013.
View Article : Google Scholar
|
|
9
|
Promrat K, Kleiner DE, Niemeier HM, et al:
Randomized controlled trial testing the effects of weight loss on
nonalcoholic steatohepatitis. Hepatology. 51:121–129. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abe N, Honda S and Jahng D: Evaluation of
waist circumference cut-off values as a marker for fatty liver
among Japanese workers. Saf Health Work. 3:287–293. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rafiq N, Bai C, Fang Y, et al: Long-term
follow-up of patients with nonalcoholic fatty liver. Clin
Gastroenterol Hepatol. 7:234–238. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eguchi Y, Hyogo H, Ono M, et al:
Prevalence and associated metabolic factors of nonalcoholic fatty
liver disease in the general population from 2009 to 2010 in Japan:
a multicenter large retrospective study. J Gastroenterol.
47:586–595. 2012. View Article : Google Scholar
|
|
13
|
Haukeland JW, Konopski Z, Eggesbo HB, et
al: Metformin in patients with non-alcoholic fatty liver disease: a
randomized, controlled trial. Scand J Gastroenterol. 44:853–860.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vernon G, Baranova A and Younossi ZM:
Systematic review: the epidemiology and natural history of
non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
in adults. Aliment Pharmacol Ther. 34:274–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nelson A, Torres DM, Morgan AE, Fincke C
and Harrison SA: A pilot study using simvastatin in the treatment
of nonalcoholic steatohepatitis: A randomized placebo-controlled
trial. J Clin Gastroenterol. 43:990–994. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Alvarez F, Berg PA, Bianchi FB, et al:
International Autoimmune Hepatitis Group Report: review of criteria
for diagnosis of autoimmune hepatitis. J Hepatol. 31:929–938. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lindor KD, Gershwin ME, Poupon R, Kaplan
M, Bergasa NV and Heathcote EJ; American Associaiton for Study of
Liver Diseases. Primary biliary cirrhosis. Hepatology. 50:291–308.
2009. View Article : Google Scholar
|
|
18
|
Matsumoto T, Yamasaki S, Arakawa A, et al:
Exposure to a high total dosage of glucocorticoids produces
non-alcoholic steatohepatits. Pathol Int. 57:388–389. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Khan N, Abbas AM, Whang N, Balart LA,
Bazzano LA and Kelly TN: Incidence of liver toxicity in
inflammatory bowel disease patients treated with methotrexate: a
meta-analysis of clinical trials. Inflamm Bowel Dis. 18:359–367.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sanyal AJ; American Gastroenterological
Association. AGA technical review on nonalcoholic fatty liver
disease. Gastroenterology. 123:1705–1725. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bedogni G, Miglioli L, Masutti F,
Tiribelli C, Marchesini G and Bellentani S: Prevalence of and risk
factors for nonalcoholic fatty liver disease: the Dionysos
nutrition and liver study. Hepatology. 42:44–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nakahara T, Hyogo H, Yoneda M, et al;
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).
Type 2 diabetes mellitus is associated with the fibrosis severity
in patients with nonalcoholic fatty liver disease in a large
retrospective cohort of Japanese patients. J Gastroenterol. Nov
26–2013.(Epub ahead of print).
|
|
23
|
Ma H, Xu C, Xu L, Yu C, Miao M and Li Y:
Independent association of HbA1c and nonalcoholic fatty liver
disease in an elderly Chinese population. BMC Gastroenterol.
13:32013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sung KC, Kim BS, Cho YK, et al: Predicting
incident fatty liver using simple cardio-metabolic risk factors at
baseline. BMC Gastroenterol. 12:842012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lottenberg AM, Afonso Mda S, Lavrador MS,
Machado RM and Nakandakare ER: The role of dietary fatty acids in
the pathology of metabolic syndrome. J Nutr Biochem. 23:1027–1040.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wiernsperger N: Hepatic function and the
cardiometabolic syndrome. Diabetes Metab Syndr Obes. 6:379–388.
2013. View Article : Google Scholar
|
